Safety and Tolerability of the Switch from Buprenorphine to Buprenorphine/Naloxone in an Italian Addiction Treatment Centre

@article{Stimolo2010SafetyAT,
  title={Safety and Tolerability of the Switch from Buprenorphine to Buprenorphine/Naloxone in an Italian Addiction Treatment Centre},
  author={Clementina Stimolo and Valentina Del Favero and Giancarlo Zecchinato and Roberto Buson and Davide Cusin and Patrizia Pellachin and Pamela Simonetto},
  journal={Clinical Drug Investigation},
  year={2010},
  volume={30},
  pages={27-31}
}
AbstractBackground: Abuse and misuse of pharmacological therapies represent major challenges in the healthcare system, particularly in patients receiving long-acting opioid drugs for the treatment of heroin or opioid addiction. The partial μ-opioid receptor agonist buprenorphine is used to treat opioid dependence, but diversion and misuse may occur. The sublingual combination formulation of buprenorphine and the opioid receptor antagonist naloxone (buprenorphine/naxolone) is associated with a… CONTINUE READING
BETA